Veracyte, Inc.

Cancer Genomic Testing & Molecular Diagnostics | Veracyte Inc.

Founded 2008

South San Francisco, United States 748 employees IPO Total: $1.15B Biotechnology, Health Care

General Information

Company Name Veracyte, Inc.

Founded Year 2008

Location

South San Francisco, United States

Founders / Decision Makers

Employees 748

Industries Biotechnology, Health Care

Funding Stage IPO

Business Model B2B, D2C, B2D

Revenue Model Product Sales, Service Fee, Usage Based

Offices as of Aug 2026

South San Francisco, United States Austin, United States

Social

BounceWatch is an independent company data service, not affiliated with Veracyte, Inc.. To contact Veracyte, Inc., visit veracyte.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Veracyte, Inc. compare?

A PDF of Veracyte, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Veracyte, Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Event Participation Oct 03, 2026

The Veracyte team is attending the College of American Pathologists’ 2026 Annual Meeting in Las Vegas, from October 3rd to 6th, to highlight advancements.

Get alerts when Veracyte, Inc. shows new signals

About Veracyte, Inc.

Veracyte, Inc., founded in 2008 and headquartered in the United States, operates within the Biotechnology and Health Care industries. The company's slogan, "Cancer Genomic Testing & Molecular Diagnostics | Veracyte Inc.," encapsulates its core mission: delivering high-value diagnostic insights that empower clinicians during crucial cancer-related decision-making moments.

With a growing portfolio of diagnostic tests, Veracyte aims to address critical clinical questions. This enables patients to avoid unnecessary procedures and accelerates the timeline toward appropriate treatment, thus enhancing patient outcomes while potentially reducing healthcare costs.

Recently, Veracyte received a $220.00K post-IPO equity investment from Kaigen Pharma on 01 May 2024. This latest funding underscores investor confidence in the company's strategic direction and growth potential in the high-demand field of cancer diagnostics.

Business keywords: Genomic Diagnostics, Cancer Diagnostics, Molecular Diagnostics, Thyroid Cancer Testing, Lung Cancer Testing, Breast Cancer Testing, Idiopathic Pulmonary Fibrosis Testing, Lymphoma Subtyping, Diagnostic Instrument Platform, Patient Care Improvement, Genomic Science Advancements, Cancer Treatment Guidance, Clinical Decision Support, Global Diagnostics Company, Cost-effective Diagnostics

Services & Products

Genomic Sequencing Classifier

Bladder Genomic Classifier

Prostate Genomic Classifier

Breast Risk of Recurrence Test

Monitoring Test for MIBC

Target Customers

Clinicians Cancer Patients Healthcare Providers Research Scientists Oncology Clinics

Funding Rounds & Investors (12)

View All

Funding Stage	Amount	Investors	Lead Investors	Date
Post-IPO Equity	$220.00K	1	Kaigen Pharma	01 May 2024
Post-IPO Equity	$550.00M	-		01 Feb 2021
Post-IPO Equity	$194.00M	-		01 Aug 2020
Post-IPO Equity	$137.80M	-		01 May 2019
Post-IPO Equity	$55.10M	-		01 Jul 2018
Post-IPO Equity	$30.00M	-		01 Nov 2016
Post-IPO Equity	$45.00M	-		01 Mar 2016
IPO	$65.00M	-		01 Oct 2013
Series C	$28.00M	5	Kleiner Perkins, GE Ventures +3	01 Jun 2013
Growth Equity VC	$15.00M	3	Kleiner Perkins, Domain Associates +1	01 Oct 2012

View All 12 Funding Rounds

Veracyte, Inc. Alternatives & Competitors

View All Alternatives

Veracyte, Inc. vs

Agendia United States

MammaPrint® + BluePrint® provides you with actionable insights throughout your patient’s breast canc...

Private Equity

209 employees

Biotechnology, Health Care

Compare Veracyte, Inc. vs Agendia

Veracyte, Inc. vs

N-of-One, Inc. United States

Relevant, timely precision oncology treatment options drive real world impact. N-of-One is now part...

Series B

9 employees

Biotechnology, Health Care

Veracyte, Inc. vs

Pierian United States

Genomics in Practice

Venture round

55 employees

Biotechnology, Health Care

Also compare with:

Variantyx View all alternatives

FAQ About Veracyte, Inc.

Cancer Genomic Testing & Molecular Diagnostics | Veracyte Inc.

Veracyte, Inc. was founded in 2008.

Veracyte, Inc. is headquartered in South San Francisco, United States. As of Aug 2026, it also has offices in Austin, United States.

Veracyte, Inc. operates in Biotechnology and Health Care. Its work centres on Genomic Diagnostics, Cancer Diagnostics, Molecular Diagnostics and Thyroid Cancer Testing. Its customers include Clinicians, Cancer Patients and Healthcare Providers.

Veracyte, Inc. has a B2B, D2C and B2D business model. Its revenue comes from Product Sales, Service Fee and Usage Based.

Veracyte, Inc. has approximately 748 employees.

Veracyte, Inc. has completed 12 funding rounds, raising a total of $1.15B. The latest funding stage is IPO.

Veracyte, Inc. offers: Genomic Sequencing Classifier, Bladder Genomic Classifier, Prostate Genomic Classifier, Breast Risk of Recurrence Test, Monitoring Test for MIBC.

Top alternatives and competitors to Veracyte, Inc. include Agendia, N-of-One, Inc., Pierian, OncoHost, Ashion Analytics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Veracyte, Inc. and Agendia are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Veracyte, Inc., https://bouncewatch.com/company/veracyte-inc, updated 30 August 2026. When citing, please name BounceWatch and link this page.

Veracyte, Inc.

General Information

Discover More

What changed at Veracyte, Inc. recently?

About Veracyte, Inc.

Services & Products

Target Customers

Funding Rounds & Investors (12)

Veracyte, Inc. Alternatives & Competitors

FAQ About Veracyte, Inc.